Ani Pharmaceuticals (ANIP) Net Margin (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Net Margin of 12.42% for Q1 2026, up 11.62% sequentially from 11.13% in Q4 2025, and up 467.0% YoY from 2.19% in Q1 2025.
Ani Pharmaceuticals (ANIP) Net Margin (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Net Margin for 16 years, with the latest figure at 12.42% in Q1 2026.
- Quarterly Net Margin rose 467.0% year-over-year to 12.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.89% (up 1326.0% YoY) and the FY2025 annual result came in at 8.74%, up 1202.0% from the prior year.
- Net Margin improved to 12.42% in Q1 2026 per ANIP's latest filing, from 11.13% in the prior quarter.
- Over five years, Net Margin peaked at 12.95% in Q1 2024 and troughed at 31.85% in Q1 2022.
- A 5-year average of 1.12% and a median of 0.97% in 2023 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 3499 bps in 2022, down 3257 bps in 2022.
- Over 5 years, Net Margin stood at 4.93% in 2022, then surged by 112 bps to 0.57% in 2023, then slumped by 1085 bps to 5.61% in 2024, then jumped by 299 bps to 11.13% in 2025, then advanced by 12 bps to 12.42% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 12.42%, 11.13%, and 11.53% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 9.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.28% |
| Mar 31, 2026 | 12.42% |
| Dec 31, 2025 | 11.13% |
| Sep 30, 2025 | 11.53% |
| Jun 30, 2025 | 3.85% |
| Mar 31, 2025 | 7.75% |
| Dec 31, 2024 | -5.61% |
| Sep 30, 2024 | -16.57% |
| Jun 30, 2024 | -1.95% |
| Mar 31, 2024 | 12.95% |
| Dec 31, 2023 | 0.57% |
| Sep 30, 2023 | 7.23% |
| Jun 30, 2023 | 5.01% |
| Mar 31, 2023 | 0.97% |
| Dec 31, 2022 | -4.93% |
| Sep 30, 2022 | -10.74% |
| Jun 30, 2022 | -20.76% |
| Mar 31, 2022 | -31.85% |
| Dec 31, 2021 | -39.93% |
| Sep 30, 2021 | -8.54% |